Jiangsu Hualan Stock Hits Day Low of CNY 77 Amid Price Pressure

Jiangsu Hualan New Pharmaceutical Material Co., Ltd. experienced a notable decline today, with the stock dropping by 3.5% on February 24, 2026. The stock reached an intraday low of CNY 77.00, reflecting a challenging trading environment. Over the past week, the company's performance has been particularly weak, with a decrease of 7.19%, contrasting sharply with the China Shanghai Composite, which saw a slight increase of 0.41%. In the longer term, Jiangsu Hualan has shown significant volatility, with a remarkable 306.18% increase over the past year, although this is juxtaposed against a backdrop of declining net sales and operating profit over the last five years. Key financial metrics indicate a low return on capital employed (ROCE) of 9.64%, suggesting limited profitability relative to total capital. The company has also reported negative results for the last three consecutive quarters, with a net profit decline of 71.07%. Despite a high dividend yield of 0.1%, the stock's price-to-earnings ratio stands at 151.00, indicating a potentially expensive valuation in the current market context.